Dr. Anna Hansen, MD

NPI: 1659419513
Total Payments
$141.75
2021 Payments
$27.71
Companies
5
Transactions
6
Medicare Patients
9,565
Medicare Billing
$848,739

Payment Breakdown by Category

Food & Beverage$141.75 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $141.75 6 100.0%

Top Paying Companies

Company Total Records Latest Year
Valeant Pharmaceuticals North America LLC $49.24 2 $0 (2017)
HOLOGIC INC $27.71 1 $0 (2021)
Dendreon Pharmaceuticals LLC $24.87 1 $0 (2017)
Merge Healthcare Incorporated $24.09 1 $0 (2019)
Siemens Medical Solutions USA, Inc. $15.84 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2021 $27.71 1 HOLOGIC INC ($27.71)
2019 $24.09 1 Merge Healthcare Incorporated ($24.09)
2018 $15.84 1 Siemens Medical Solutions USA, Inc. ($15.84)
2017 $74.11 3 Valeant Pharmaceuticals North America LLC ($49.24)

All Payment Transactions

6 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
05/17/2021 HOLOGIC INC BREVERA BREAST BIOPSY SYSTEM (Device) Food and Beverage In-kind items and services $27.71 General
Category: Breast and Skeletal Health
10/15/2019 Merge Healthcare Incorporated Enterprise Archive (Device) Food and Beverage Cash or cash equivalent $24.09 General
Category: Medical Imaging
02/14/2018 Siemens Medical Solutions USA, Inc. SPECT Symbia Intevo (Device) Food and Beverage In-kind items and services $15.84 General
Category: MI - Nuclear Medicine (incl. PETNET & MIBR)
07/31/2017 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $24.87 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
04/19/2017 Valeant Pharmaceuticals North America LLC PROVENGE (Drug) Food and Beverage In-kind items and services $22.76 General
Category: ONCOLOGY
02/07/2017 Valeant Pharmaceuticals North America LLC PROVENGE (Drug) Food and Beverage In-kind items and services $26.48 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 2,929 2,953 $758,456 $228,074
2022 13 1,846 1,890 $620,794 $183,665
2021 12 2,126 2,148 $681,347 $208,824
2020 12 2,664 2,688 $689,289 $228,176
Total Patients
9,565
Total Services
9,679
Medicare Billing
$848,739
Procedure Codes
47

All Medicare Procedures & Services

47 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
77067 Screening mammography Office 2023 1,146 1,153 $421,930 $133,203 31.6%
77063 Screening 3d breast mammography Office 2023 1,146 1,153 $178,086 $56,590 31.8%
77080 Dxa bone density measurement of hip, pelvis, spine Office 2023 332 332 $39,176 $12,810 32.7%
77065 Diagnostic mammography of 1 breast Office 2023 82 90 $35,334 $7,461 21.1%
19083 Biopsy of breast and placement of locating device using ultrasound, first growth Office 2023 17 17 $33,898 $7,023 20.7%
76642 Limited ultrasound scan of 1 breast Office 2023 67 67 $18,274 $4,205 23.0%
77066 Diagnostic mammography of both breasts Office 2023 30 30 $13,826 $3,199 23.1%
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) Office 2023 82 83 $13,760 $3,082 22.4%
38792 Injection of radioactive material for x-ray identification of lymph node Facility 2023 12 12 $3,420 $306.89 9.0%
76098 X-ray of surgical specimen Facility 2023 15 16 $752.00 $194.00 25.8%
77067 Screening mammography Office 2022 631 635 $230,133 $77,453 33.7%
77063 Screening 3d breast mammography Office 2022 631 635 $96,952 $32,286 33.3%
19083 Biopsy of breast and placement of locating device using ultrasound, first growth Office 2022 39 41 $70,479 $17,839 25.3%
77065 Diagnostic mammography of 1 breast Office 2022 115 138 $52,992 $13,071 24.7%
77066 Diagnostic mammography of both breasts Office 2022 75 75 $36,450 $8,364 22.9%
77049 Mri scan of both breasts Office 2022 23 23 $26,611 $6,747 25.4%
76642 Limited ultrasound scan of 1 breast Office 2022 94 101 $26,850 $6,576 24.5%
19285 Placement of locating device in breast using ultrasound guidance, first growth Office 2022 19 19 $24,586 $6,117 24.9%
19081 Biopsy of breast and placement of locating device using x-ray with needle, first growth Office 2022 12 13 $22,321 $5,584 25.0%
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) Office 2022 139 139 $22,379 $5,470 24.4%
19281 Placement of locating device in breast using imaging guidance, first growth Office 2022 14 16 $4,608 $3,228 70.0%
38792 Injection of radioactive material for x-ray identification of lymph node Facility 2022 18 18 $4,731 $471.04 10.0%
76098 X-ray of surgical specimen Facility 2022 36 37 $1,702 $460.65 27.1%
77067 Screening mammography of both breasts Office 2021 804 804 $325,170 $107,202 33.0%
77063 Screening digital tomography of both breasts Office 2021 804 804 $130,534 $44,122 33.8%

About Dr. Anna Hansen, MD

Dr. Anna Hansen, MD is a Diagnostic Radiology healthcare provider based in Wenatchee, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1659419513.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anna Hansen, MD has received a total of $141.75 in payments from pharmaceutical and medical device companies, with $27.71 received in 2021. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($141.75).

As a Medicare-enrolled provider, Hansen has provided services to 9,565 Medicare beneficiaries, totaling 9,679 services with total Medicare billing of $848,739. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.

Practice Information

  • Specialty Diagnostic Radiology
  • Location Wenatchee, WA
  • Active Since 02/02/2007
  • Last Updated 08/07/2013
  • Taxonomy Code 2085R0202X
  • Entity Type Individual
  • NPI Number 1659419513

Products in Payments

  • PROVENGE (Drug) $74.11
  • BREVERA BREAST BIOPSY SYSTEM (Device) $27.71
  • Enterprise Archive (Device) $24.09
  • SPECT Symbia Intevo (Device) $15.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Diagnostic Radiology Doctors in Wenatchee